strictly private and confidential...ltm q1 2016 % change ltm q1 2016 % change quarterly tech report...
Post on 25-Aug-2020
3 Views
Preview:
TRANSCRIPT
STRICTLY PRIVATE AND CONFIDENTIAL
1QUARTERLY TECH REPORT – Q1: HEALTHTECH
2QUARTERLY TECH REPORT – Q1: HEALTHTECH
DEEP DOMAIN EXPERTISE IN THREE INTER-RELATED SECTORS… …AND AN INTERNATIONAL TRACK RECORD
A MARKET-LEADING CORPORATE FINANCE ADVISORY FIRM… …WITH GLOBAL REACH
•
•
•
•
•
•
•
3QUARTERLY TECH REPORT – Q1: HEALTHTECH
LAST
12 M
ON
TH S
HA
RE P
RIC
E P
ER
FO
RM
AN
CE
Q1 2016 PERFORMANCE
4QUARTERLY TECH REPORT – Q1: HEALTHTECHLA
ST
12 M
ON
THS
Q1 2
016
HEALTHCARE IT - EUROPE HEALTHCARE IT - US BIOPHARMA IT
5QUARTERLY TECH REPORT – Q1: HEALTHTECH
COMPANYIPO
DATEDESCRIPTION
RAISED ($M)
INDICATIVE PRICE RANGE ($)
IPO LISTING PRICE ($)
INCREASE VS. RANGE
DAY 1 INCREASE
CURRENT INCREASE(1)
CURRENT EV ($M)
EV / REVENUE 2016E
EV / EBITDA 2016E
6QUARTERLY TECH REPORT – Q1: HEALTHTECH
REVENUE GROWTH (2016-17E) EV / REVENUE 2016E
EBITDA MARGIN 2016E EV / EBITDA 2016E
7
LTM Q1 2016
% CHANGE
LTM Q1 2016
% CHANGE
QUARTERLY TECH REPORT – Q1: HEALTHTECH
8QUARTERLY TECH REPORT – Q1: HEALTHTECH
NU
MB
ER
OF D
EA
LS
TOTA
L D
ISC
LOSED
DEA
L V
ALU
E (
$M
)
9QUARTERLY TECH REPORT – Q1: HEALTHTECH
DATE BUYER TARGET EV ($M) EV/REVENUE EV/EBITDA COMPANY DESCRIPTIONTARGET
LOCATION
10QUARTERLY TECH REPORT – Q1: HEALTHTECH
DATE COMPANYTYPE OF ROUND
FUNDSRAISED ($M)
INVESTOR PARTICIPATION COMPANY DESCRIPTIONCOMPANYLOCATION
11
OPERATING METRICS VALUATION METRICS
PRICE % OF 52 MARKET TOTAL NET ENTERPRISE REVENUE REV. GROWTH GROSS MARGIN REVENUE EBITDA
COMPANY (31-MAR-16) WEEK HIGH CAP CASH DEBT VALUE CY2016 CY16-17 HISTORICAL CY2016 CY2017 CY2016 CY2017 CY2016 CY2017
GENERALISTS WITH SIGNIFICANT HEALTHTECH EXPOSURE
HEALTHCARE IT - EUROPE
HEALTHCARE IT - US
BIOPHARMA IT
EBITDA MARGIN
QUARTERLY TECH REPORT – Q1: HEALTHTECH
12QUARTERLY TECH REPORT – Q1: HEALTHTECH
MANAGER - LONDON PARTNER – NEW YORKPARTNER – LONDON PARTNER – NEW YORK PARTNER – APAC
top related